Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINA

BACKGROUND: This study aimed to elucidate visual benefits of ranibizumab in patients with neovascular age-related macular degeneration (nAMD) compared with control arms and identify factors affecting response. METHODS: This is a post-hoc pooled analysis of two phase III studies, ANCHOR and MARINA, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tufail, Adnan, Margaron, Philippe, Guerin, Tadhg, Larsen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212932/
https://www.ncbi.nlm.nih.gov/pubmed/31562118
http://dx.doi.org/10.1136/bjophthalmol-2018-313682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212932/
https://www.ncbi.nlm.nih.gov/pubmed/31562118
http://dx.doi.org/10.1136/bjophthalmol-2018-313682

Ejemplares similares